Apple Defeats Bid for New Apple Watch Import Ban at US Trade Tribunal

Why It Matters

The decision clears a major regulatory hurdle, preserving Apple’s revenue stream from its flagship wearables and maintaining its competitive edge in health monitoring. It also underscores the ongoing risk of patent litigation for tech firms expanding into medical‑grade sensors.

Key Takeaways

• ITC upheld Apple’s redesign, keeping Series 9 and Ultra 2 imports allowed
• Masimo’s earlier ban stemmed from patent claims on pulse‑oximetry tech
• Apple’s updated watches route blood‑oxygen data to iPhone, bypassing watch display
• Masimo may appeal; its $634 million patent verdict remains pending

Pulse Analysis

The dispute between Apple and Masimo has been a textbook case of how patent enforcement can intersect with consumer electronics. After the International Trade Commission initially blocked imports of the Series 9 and Ultra 2 models in late 2023, Apple responded by redesigning the watches to offload blood‑oxygen data to the iPhone. This technical workaround satisfied U.S. Customs, allowing the devices back into the market while preserving the health‑monitoring feature that differentiates Apple’s wearables from competitors.

Apple’s redesign highlights a broader trend: device makers are increasingly engineering around patents rather than engaging in costly litigation. By shifting the display of oxygen saturation metrics to a paired smartphone, Apple avoided the specific claim that Masimo held on on‑watch readouts. The move not only kept a lucrative product line on shelves but also reinforced Apple’s reputation for rapid, user‑focused innovation in the health‑tech space, a key growth driver as consumers demand more clinical‑grade data from everyday gadgets.

For the industry, the ITC’s ruling signals that patent holders must present a compelling case to sustain import bans, especially when defendants can demonstrate functional redesigns. Masimo’s ability to appeal and its recent $634 million judgment in a separate California case keep the legal pressure on Apple, but the immediate effect is stability for Apple’s wearables revenue and confidence for investors. The outcome may encourage other tech firms to adopt similar design‑by‑exception strategies, reshaping how patent disputes are resolved in fast‑moving hardware markets.